Texas Capital Bancshares Pref B ADR
TCBIO
Texas Capital Bancshares Pref B ADR (TCBIO) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.83
- EPS estimate
- $1.87
- EPS surprise
- −2.36%
- Revenue surprise
- +0.64%
- Revenue
- $335.5M
- Revenue estimate
- $333.4M
- Reported
- Jul 22, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 22, 2026 | $1.87 | $1.83 | −2.36% | $335.5M | SEC |
| Q1 2026 | Apr 23, 2026 | $1.40 | $1.56 | +11.12% | $324.0M | SEC |
| Q4 2025 | Jan 22, 2026 | $1.76 | $2.12 | +20.19% | $327.5M | SEC |
| Q3 2025 | Oct 22, 2025 | $1.77 | $2.18 | +22.94% | $340.4M | SEC |
| Q2 2025 | Jul 17, 2025 | $1.29 | $1.58 | +22.76% | $307.5M | SEC |
| Q1 2025 | Apr 17, 2025 | $0.95 | $0.92 | −3.44% | $280.5M | SEC |
| Q4 2024 | Jan 23, 2025 | $1.09 | $1.43 | +31.35% | $283.7M | SEC |
| Q3 2024 | Oct 17, 2024 | −$1.98 | −$1.41 | +28.77% | $304.9M | SEC |
| Q2 2024 | Jul 18, 2024 | $0.86 | $0.80 | −7.11% | $267.0M | SEC |
| Q1 2024 | Apr 18, 2024 | $0.58 | $0.46 | −20.69% | $256.3M | SEC |
| Q4 2023 | Jan 18, 2024 | $0.57 | $0.33 | −42.30% | $245.8M | SEC |
| Q3 2023 | Oct 19, 2023 | $1.01 | $1.18 | +17.30% | $278.9M | SEC |
| Q2 2023 | Jul 20, 2023 | $0.95 | $1.33 | +39.76% | $278.0M | SEC |
| Q1 2023 | Apr 20, 2023 | $0.87 | $0.70 | −19.14% | $272.7M | SEC |
| Q4 2022 | Jan 18, 2023 | $0.94 | $4.23 | +350.00% | $276.7M | SEC |
| Q3 2022 | Oct 19, 2022 | $0.98 | $0.74 | −24.52% | $264.4M | SEC |
| Q2 2022 | Jul 21, 2022 | $0.71 | $0.59 | −17.13% | $231.8M | SEC |
| Q1 2022 | Apr 20, 2022 | $0.73 | $0.69 | −5.47% | $203.8M | SEC |
| Q4 2021 | Jan 20, 2022 | $0.91 | $1.19 | +30.83% | $225.5M | SEC |
| Q3 2021 | Oct 20, 2021 | $1.09 | $0.76 | −30.57% | $215.3M | SEC |
Quarterly revenue
Frequently asked questions
When did Texas Capital Bancshares Pref B ADR (TCBIO) last report earnings?
Texas Capital Bancshares Pref B ADR last reported on Jul 22, 2026, covering fiscal Q2 2026.
Did TCBIO beat earnings estimates?
No. Texas Capital Bancshares Pref B ADR reported EPS of $1.83 for Q2 2026 against a $1.87 estimate — a 2.36% miss.
How much revenue did TCBIO report last quarter?
Texas Capital Bancshares Pref B ADR reported $335.5M in revenue for Q2 2026, against a consensus estimate of $333.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.